Tags

Type your tag names separated by a space and hit enter

Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. beth.conlon@phd.einstein.yu.edu.

    , , ,

    Source

    Nutrients 5:10 2013 Oct 11 pg 4093-114

    MeSH

    Cardiovascular Diseases
    Diabetes Mellitus
    Diet
    Dietary Carbohydrates
    Dietary Fats
    Dietary Proteins
    Evidence-Based Medicine
    Fatty Liver
    Humans
    Insulin Resistance
    Liver Diseases
    Micronutrients
    Motor Activity
    Non-alcoholic Fatty Liver Disease
    Obesity
    Randomized Controlled Trials as Topic
    Recommended Dietary Allowances
    Weight Loss

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    24152749

    Citation

    Conlon, Beth A., et al. "Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)." Nutrients, vol. 5, no. 10, 2013, pp. 4093-114.
    Conlon BA, Beasley JM, Aebersold K, et al. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients. 2013;5(10):4093-114.
    Conlon, B. A., Beasley, J. M., Aebersold, K., Jhangiani, S. S., & Wylie-Rosett, J. (2013). Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients, 5(10), pp. 4093-114. doi:10.3390/nu5104093.
    Conlon BA, et al. Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD). Nutrients. 2013 Oct 11;5(10):4093-114. PubMed PMID: 24152749.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). AU - Conlon,Beth A, AU - Beasley,Jeannette M, AU - Aebersold,Karin, AU - Jhangiani,Sunil S, AU - Wylie-Rosett,Judith, Y1 - 2013/10/11/ PY - 2013/05/18/received PY - 2013/08/14/revised PY - 2013/09/19/accepted PY - 2013/10/25/entrez PY - 2013/10/25/pubmed PY - 2014/5/9/medline SP - 4093 EP - 114 JF - Nutrients JO - Nutrients VL - 5 IS - 10 N2 - Nonalcoholic fatty liver disease (NAFLD) is an emerging global health concern. It is the most common form of chronic liver disease in Western countries, affecting both adults and children. NAFLD encompasses a broad spectrum of fatty liver disease, ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH), and is strongly associated with obesity, insulin resistance, and dyslipidemia. First-line therapy for NAFLD includes weight loss achieved through diet and physical activity. However, there is a lack of evidenced-based dietary recommendations. The American Diabetes Association's (ADA) recommendations that aim to reduce the risk of diabetes and cardiovascular disease may also be applicable to the NAFLD population. The objectives of this review are to: (1) provide an overview of NAFLD in the context of insulin resistance, and (2) provide a rationale for applying relevant aspects of the ADA recommendations to the nutritional management of NAFLD. SN - 2072-6643 UR - https://www.unboundmedicine.com/medline/citation/24152749/Nutritional_management_of_insulin_resistance_in_nonalcoholic_fatty_liver_disease__NAFLD__ L2 - http://www.mdpi.com/resolver?pii=nu5104093 DB - PRIME DP - Unbound Medicine ER -